|1.||Suleyman, Halis: 5 articles (11/2012 - 05/2007)|
|2.||Hacimuftuoglu, Ahmet: 4 articles (07/2012 - 05/2007)|
|3.||Polat, Beyzagul: 3 articles (11/2012 - 01/2010)|
|4.||Cadirci, Elif: 3 articles (04/2010 - 05/2007)|
|5.||Halici, Zekai: 3 articles (04/2010 - 05/2007)|
|6.||Endo, Keigo: 3 articles (04/2007 - 01/2003)|
|7.||Oriuchi, Noboru: 3 articles (04/2007 - 01/2003)|
|8.||Hasler, Gregor: 2 articles (03/2015 - 10/2011)|
|9.||Gundogdu, Cemal: 2 articles (07/2012 - 04/2010)|
|10.||Albayrak, Abdulmecit: 2 articles (04/2010 - 01/2010)|
04/28/1997 - "Metyrosine and pheochromocytoma."
11/01/1990 - "Surgical management of pheochromocytoma with the use of metyrosine."
05/01/1990 - "A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and alpha-methyl-p-tyrosine."
11/01/1988 - "For patients with inoperable, malignant, recurrent, or multicentric pheochromocytomas, chronic medical therapy is indicated in the form of alpha- and/or beta-blockade or inhibition of catecholamine synthesis with alpha-methyl-para-tyrosine. "
11/01/1985 - "Other investigators have advocated alpha-methyltyrosine as the medical therapy of choice in the preoperative preparation of patients with pheochromocytoma. "
01/01/1998 - "Rasagiline at 0.5 mg/kg/day was protective against alpha-MpT also in hypoxia-lesioned rats. "
04/01/1986 - "Similarly, treatment with alpha-methyl-p-tyrosine decreased the ability of chemoreceptors to respond to hypoxia and hypercapnia and, in a few instances, these receptors could only be excited by superfusion of nitrogen-equilibrated medium. "
06/01/1978 - "5. The animals were exposed to alternate periods of hypoxia and hyperoxia following administration of the tyrosine hydroxylase inhibitor alpha-methyl p-tyrosine (AMPT, 0.2-10 mg/kg, I.A.). "
08/01/1996 - "Reserpine (which depletes dopamine stores) but not alpha-methyl-para-tyrosine (which decreases de novo synthesis of dopamine) caused a marked attenuation of this hyperpolarisation [IR decrease only from 163.32 +/- 44.42 M omega pre-hypoxia to 154.42 +/- 50.97 M omega during hypoxia]. "
07/15/1996 - "Depleting the brain of catecholamines prior to hypoxia, by treating the animals with alpha-methyl-p-tyrosine (AMT), resulted in a major change in the hsp72 mRNA expression. "
|3.||Body Weight (Weight, Body)
06/01/1983 - "Ten hr prior to the microinjection, alpha-methyl-p-tyrosine (250 mg/kg body weight) was intraperitoneally injected to prevent spontaneous pulsatile GH release. "
06/01/1983 - "Ethanol (1-1.5 g/kg body weight, i.p.) improved acquisition of active avoidance responding only in ALA, whereas alpha-methyl-p-tyrosine (AMPT; 80 mg/kg body weight, i.p.) seemed to selectively impair acquisition of responding in AHA. "
06/01/2010 - "fossilis collected in both prespawning and spawning phases were given alpha-methylparatyrosine (alpha-MPT: 250 microg/g body weight, ip, an irreversible inhibitor of TH) and human chorionic gonadotropin (hCG: 100 IU/fish, ip) alone or in combination. "
01/10/2000 - "Dopamine depletion was achieved by per-oral administration of 5.5 g/70 kg body weight alpha-methyl-para-tyrosine given in 37 h. "
06/01/1979 - "Morphine (1.67, 5, and 15 mg/kg of body weight, intraperitoneally) altered dopamine turnover as measured by the alpha-methyl-p-tyrosine method in the median eminence, neostriatum, and frontal cortex of male Sprague-Dawley rats. "
|4.||Seasonal Affective Disorder
|2.||Ethanol (Ethyl Alcohol)
|3.||Clonidine (ST 155)
|4.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|10.||Levodopa (L Dopa)
|4.||Drug Therapy (Chemotherapy)